June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Improvement of P23H rod opsin traffic after metformin treatment accelerates the rate of retinal degeneration in P23H retinitis pigmentosa
Author Affiliations & Notes
  • Dimitra Athanasiou
    ORBIT (Ocular Biology and Therapeutics), UCL, Institute of Ophthalmology, London, United Kingdom
  • Monica Aguila
    ORBIT (Ocular Biology and Therapeutics), UCL, Institute of Ophthalmology, London, United Kingdom
  • Kieron South
    School of Biological Sciences, University of Essex, Essex, United Kingdom
  • Dalila Bevilacqua
    ORBIT (Ocular Biology and Therapeutics), UCL, Institute of Ophthalmology, London, United Kingdom
  • Francesca Mackenzie
    ORBIT (Ocular Biology and Therapeutics), UCL, Institute of Ophthalmology, London, United Kingdom
  • Peter M Munro
    UCL, Institute of Opthalmology, London, United Kingdom
  • Michael Y Sherman
    Department of Biochemistry, Boston University Medical School, Boston, MA
  • Philip J Reeves
    School of Biological Sciences, University of Essex, Essex, United Kingdom
  • Michael E Cheetham
    ORBIT (Ocular Biology and Therapeutics), UCL, Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships Dimitra Athanasiou, None; Monica Aguila, None; Kieron South, None; Dalila Bevilacqua, None; Francesca Mackenzie, None; Peter Munro, None; Michael Sherman, None; Philip Reeves, None; Michael Cheetham, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1701. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dimitra Athanasiou, Monica Aguila, Kieron South, Dalila Bevilacqua, Francesca Mackenzie, Peter M Munro, Michael Y Sherman, Philip J Reeves, Michael E Cheetham; Improvement of P23H rod opsin traffic after metformin treatment accelerates the rate of retinal degeneration in P23H retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1701. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Metformin, the most commonly prescribed anti-diabetic drug, can alter the rate of protein production in the cells through the activation of AMP-activated protein kinase (AMPK). Activation of AMPK could potentially alter the folding and/or degradation of misfolded proteins, such as P23H rhodopsin that causes retinitis pigmentosa (RP). Therefore, we investigated the effect of metformin on cell culture and transgenic models expressing P23H rhodopsin.

Methods: SK-N-SH neuroblastoma cells were treated with metformin and the effect of treatment on P23H-GFP on localisation was assessed by immunofluorescence and confocal microscopy. Cell survival was assessed by lactate dehydrogenase (LDH) assay. The folding of P23H rod opsin in the presence of Metformin was assessed by absorption spectroscopy of purified rhodopsin to monitor pigment formation. P23H-1 rats were treated with either 300 mg/Kg metformin or vehicle administered daily via intraperitoneal injection and were subjected to electroretinogram (ERG) and spectral domain optical coherent tomography (SD-OCT) analysis, after which rats were sacrificed and tissue was taken for biochemical studies, histology and electron microscopy.

Results: Metformin treatment in SK-N-SH cells improved the traffic of P23H rod opsin from the ER to the plasma membrane, suggesting an improvement in mutant rod opsin folding, which was confirmed by an enhanced yield of purified P23H rhodopsin with a lambda max at 490 nm. Furthermore, similar to pharmacological chaperones metformin treatment reduced P23H-related cell death. Metformin was tested in the P23H-1 rat model in three independent drug treatments. Systemic metformin treatment increased APMK activation in the retina. Surprisingly, we observed that metformin treatment led to decreased photoreceptor function and survival. Metformin treated rats showed significantly lower ERG responses and thinner retinas compared to the vehicle-treated rats.

Conclusions: The improvement in P23H folding and traffic after metformin treatment correlated with an accelerated rate of retinal degeneration. This suggests that therapies aimed at rhodopsin RP might be better focused on enhancing degradation than improving folding. In addition, these data could be important for some RP patients, as metformin could potentially worsen their RP if prescribed for type II diabetes.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×